http://rdf.ncbi.nlm.nih.gov/pubchem/reference/22308622

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't
endingPage 108
issn 0006-2952
pageRange 98-108
publicationName Biochemical Pharmacology
startingPage 98
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_06c1a1e5cf693627305a912a6775d7d0
bibliographicCitation Tapodi A, Bognar Z, Szabo C, Gallyas F, Sumegi B, Hocsak E. PARP inhibition induces Akt-mediated cytoprotective effects through the formation of a mitochondria-targeted phospho-ATM-NEMO-Akt-mTOR signalosome. Biochem Pharmacol. 2019 Apr;162():98–108. doi: 10.1016/j.bcp.2018.10.005. PMID: 30296409.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_10200bfd2a95b38ba49c7eca2a59f6d0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a663b5be4fa8d8ac68838da14b7cbe12
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_097a9b3fb5f4e2a34d08735c80854b6e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6ffc4aa3f421f73af5030cd647c75370
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fcc3834486388685d4d5463313a9e15f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9fbbbeb4d9845e39d89046f699769297
date 201904
identifier https://doi.org/10.1016/j.bcp.2018.10.005
https://pubmed.ncbi.nlm.nih.gov/30296409
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1015
https://portal.issn.org/resource/ISSN/0006-2952
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title PARP inhibition induces Akt-mediated cytoprotective effects through the formation of a mitochondria-targeted phospho-ATM-NEMO-Akt-mTOR signalosome
discusses http://id.nlm.nih.gov/mesh/M0279189
http://id.nlm.nih.gov/mesh/M0483208
http://id.nlm.nih.gov/mesh/M0016488
http://id.nlm.nih.gov/mesh/M000613201
http://id.nlm.nih.gov/mesh/M0543256
http://id.nlm.nih.gov/mesh/M0469353
http://id.nlm.nih.gov/mesh/M0398726
http://id.nlm.nih.gov/mesh/M0469193
http://id.nlm.nih.gov/mesh/M0248389
http://id.nlm.nih.gov/mesh/M0481741
http://id.nlm.nih.gov/mesh/M0150739
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D051550Q000378
http://id.nlm.nih.gov/mesh/D058570Q000378
http://id.nlm.nih.gov/mesh/D000071137Q000378
http://id.nlm.nih.gov/mesh/D008928Q000378
http://id.nlm.nih.gov/mesh/D064007Q000378
http://id.nlm.nih.gov/mesh/D051057Q000378
hasSubjectTerm http://id.nlm.nih.gov/mesh/D010766Q000187
http://id.nlm.nih.gov/mesh/D019610Q000502
http://id.nlm.nih.gov/mesh/D010766Q000502
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D004305
http://id.nlm.nih.gov/mesh/D015398Q000502
http://id.nlm.nih.gov/mesh/D000071137Q000037
http://id.nlm.nih.gov/mesh/D015398Q000187
http://id.nlm.nih.gov/mesh/D002470Q000187
http://id.nlm.nih.gov/mesh/D006367
http://id.nlm.nih.gov/mesh/D002470Q000502
http://id.nlm.nih.gov/mesh/D008928Q000187
http://id.nlm.nih.gov/mesh/D061986
http://id.nlm.nih.gov/mesh/D010616Q000494
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_472b28cee6c37ce9d58de4aa1dc6d7ef
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9476
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_5f8f19d61252fdce5cae1f415ad035b2
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_467b750f9a6073f1098d1aa6270e135d
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fe0d872c4ea3e7d9f07488fc82841cc8
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4858
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID784
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d0bb789479d34dbc0811f92fc2bc5049

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID134223378
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53788117
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID134222742
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53790503
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID85756513

Total number of triples: 67.